"It's nice to hang out with the big kids this week,” said Joel Dahmen. Even nicer because he earned his way into the API and ...
Seth Jarvis's evolution goes beyond scoring; his all-around game and infectious personality now ignite the Hurricanes, ...
CLEVELAND, Ohio — Like Buckeye Chuck popping out of his hole, some good news finally surfaced at Cleveland’s budget hearings: The city has a new plan for its old pest problem. Cleveland is hiring ...
If your PC is running slowly or has disk errors you need to address the problem. Rather than trying to uninstall programs you could run a scan on your hard drive to fix any errors. Here’s how to do ...
The FDA has rejected a rare blood disease candidate from Disc Medicine, a compound that had been granted expedited review through a newly launched priority voucher program. While the agency agreed ...
Disc Medicine, Inc. develops novel therapeutics targeting red blood cell biology, focusing on heme biosynthesis and iron homeostasis for the treatment of serious hematologic diseases. The company ...
Disc Medicine’s effort to introduce a new therapy for a rare blood disorder with few treatment options has been derailed with the FDA turning down the application and asking for more data from another ...
READING, Pa. - Patty Pagoda has made her weather prediction. Patty saw her shadow, predicting six more weeks of winter. Groundhog Day in Reading looks a little different this year. Patty Pagoda made ...
Feb 13 (Reuters) - Disc Medicine (IRON.O), opens new tab said on Friday the U.S. Food and Drug Administration declined to approve its drug to treat a rare genetic disorder. The drug, bitopertin, was ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. Adam Feuerstein is a senior ...
Feb 17 (Reuters) - Disc Medicine (IRON.O), opens new tab said on Tuesday it will pursue a traditional U.S. approval pathway for its rare disease drug after the Food and Drug Administration declined to ...